Paul M. Palz has considerable experience in public and private equity manufacturing, distribution and service industry companies at various stages of development (start up, wind down, turn-around and mature). His experience includes treasury management, SEC (including initial public offerings, secondary offerings and related SEC filings), SOX program implementation, acquisition assessment (including reverse merger (inversion) of an Irish entity), SOX implementation and post-closing integration of those acquisitions. He has managed IT, HR, Treasury, FP&A, and accounting teams of various sizes as well as served as a confidant and business advisor to senior management and Boards.

Paul has led the implementation and/or migration of various enterprise system software platforms for international and domestic operations.

He has spent the last 5 years as VP Finance-Corporate Controller for Horizon Pharma, Inc. and VP Finance-Comptroller at Therapeutic Proteins, International.
Paul received his bachelor of business administration degree in accounting from Loyola University of Chicago. Paul began his career as a CPA at Arthur Andersen, and worked his way up via the controllership ranks at Caremark International, Allscripts, Inc., Del Global Technologies Corp., Horizon Pharma, Inc. and Therapeutic Proteins International, LLC